Early Access

10-QPeriod: Q1 FY2001

BECTON DICKINSON & CO Quarterly Report for Q1 Ended Dec 31, 2000

Filed February 12, 2001For Securities:BDX

Summary

Becton Dickinson & Co. (BDX) reported revenues of $843.3 million for the quarter ending December 31, 2000, a 2% decrease compared to the same period last year. This decline was primarily attributed to unfavorable foreign currency translation, which reduced revenues by an estimated $46 million, and a tough comparison to the prior year that benefited from year 2000-related inventory stocking. Despite the revenue dip, the company saw strong growth in safety-engineered products across its segments. Net income for the quarter was $60.6 million, or $0.23 per diluted share, down from $75.3 million, or $0.29 per diluted share, in the prior year. The company's financial condition remains solid, with total debt representing 40.8% of total capital as of December 31, 2000, down from 46.3% a year prior. BDX continues to manage its business through various strategic initiatives, including restructuring programs aimed at improving cost structure, and has adopted new accounting standards for derivative instruments. While facing ongoing legal proceedings, the company believes these will not have a material adverse effect on its consolidated financial condition.

Key Highlights

  • 1Revenue decreased by 2% to $843.3 million for the quarter ended December 31, 2000, largely due to a 5% negative impact from foreign currency translation.
  • 2Net income declined to $60.6 million from $75.3 million in the prior year's comparable quarter, resulting in diluted EPS of $0.23, down from $0.29.
  • 3Medical Systems segment revenues decreased by 5% to $438.4 million, impacted by currency fluctuations and inventory adjustments, though safety-engineered product sales showed good growth.
  • 4Clinical Laboratory Solutions and Biosciences segments reported modest revenue growth of 2% each, with Clinical Lab revenue growing 7% excluding currency impact.
  • 5The company adopted SFAS No. 133 regarding derivative instruments and hedging activities, impacting other expense/income.
  • 6Total debt as a percentage of total capital decreased to 40.8% from 46.3% in the prior year, indicating improved financial leverage.
  • 7Restructuring charges were recognized for ongoing programs aimed at improving cost structure, with a significant portion of targeted employee severances completed.

Frequently Asked Questions